264 related articles for article (PubMed ID: 10776793)
1. Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma.
Trieb K; Gerth R; Windhager R; Grohs JG; Holzer G; Berger P; Kotz R
Immunobiology; 2000 Jan; 201(3-4):368-76. PubMed ID: 10776793
[TBL] [Abstract][Full Text] [Related]
2. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
3. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
[TBL] [Abstract][Full Text] [Related]
4. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
[TBL] [Abstract][Full Text] [Related]
5. Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis.
Zlacka D; Vavrincova P; Hien Nguyen TT; Hromadnikova I
J Autoimmun; 2006 Sep; 27(2):81-8. PubMed ID: 16934956
[TBL] [Abstract][Full Text] [Related]
6. Hematogenous micrometastases in osteosarcoma patients.
Bruland OS; Høifødt H; Saeter G; Smeland S; Fodstad O
Clin Cancer Res; 2005 Jul; 11(13):4666-73. PubMed ID: 16000559
[TBL] [Abstract][Full Text] [Related]
7. Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors.
Kushlinskii NE; Alferov AA; Timofeev YS; Gershtein ES; Bulycheva IV; Bondarev AV; Shchupak MY; Sokolov NY; Polikarpova SB; Efimova MM; Dzampaev AA; Sushentsov EA; Aliev MD; Musaev ER
Bull Exp Biol Med; 2020 Nov; 170(1):64-68. PubMed ID: 33231796
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy.
Trieb K; Gerth R; Holzer G; Grohs JG; Berger P; Kotz R
Br J Cancer; 2000 Jan; 82(1):85-7. PubMed ID: 10638971
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumours.
Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
Anticancer Res; 2003; 23(3C):3057-9. PubMed ID: 12926161
[TBL] [Abstract][Full Text] [Related]
11. The impact of dialysis modality on serum heat shock proteins in children and young adults with chronic kidney disease.
Musiał K; Szczepańska M; Szprynger K; Zwolińska D
Kidney Blood Press Res; 2009; 32(5):366-72. PubMed ID: 19887824
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of APO-1/Fas and interleukin-1beta-converting enzyme in osteosarcoma correlate with response to chemotherapy.
Holzer G; Trieb K; Koschat M; Blahovec H; Kotz R
Anticancer Res; 2002; 22(3):1869-72. PubMed ID: 12168884
[TBL] [Abstract][Full Text] [Related]
13. Soluble p185(HER-2) in patients with malignant bone tumours.
Holzer G; Pfandlsteiner T; Koschat M; Noske H; Trieb K; Kotz R
Pediatr Blood Cancer; 2005 Feb; 44(2):163-6. PubMed ID: 15468309
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy.
Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
Hum Pathol; 1998 Oct; 29(10):1050-5. PubMed ID: 9781640
[TBL] [Abstract][Full Text] [Related]
15. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
[TBL] [Abstract][Full Text] [Related]
17. Concentration of soluble CD44 standard and soluble CD44 variant V5 in the serum of patients with malignant bone tumors.
Holzer G; Kittl E; Pfandelsteiner T; Trieb K; Kotz R
Med Pediatr Oncol; 2003 Jan; 40(1):64-5. PubMed ID: 12426692
[No Abstract] [Full Text] [Related]
18. Antibodies to 60, 65 and 70 kDa heat shock proteins in pediatric allogeneic stem cell transplant recipients.
Zlacka D; Sedlacek P; Prucha M; Hromadnikova I
Pediatr Transplant; 2006 Nov; 10(7):794-804. PubMed ID: 17032425
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.
Schett G; Xu Q; Amberger A; Van der Zee R; Recheis H; Willeit J; Wick G
J Clin Invest; 1995 Dec; 96(6):2569-77. PubMed ID: 8675620
[TBL] [Abstract][Full Text] [Related]
20. Elevated anti-heat shock protein 60 antibody titer is related to white matter hyperintensities.
Kimura A; Sakurai T; Yamada M; Koumura A; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
J Stroke Cerebrovasc Dis; 2012 May; 21(4):305-9. PubMed ID: 20947377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
